CN103230478B - 一种富硒纳豆制品 - Google Patents
一种富硒纳豆制品 Download PDFInfo
- Publication number
- CN103230478B CN103230478B CN201310158684.3A CN201310158684A CN103230478B CN 103230478 B CN103230478 B CN 103230478B CN 201310158684 A CN201310158684 A CN 201310158684A CN 103230478 B CN103230478 B CN 103230478B
- Authority
- CN
- China
- Prior art keywords
- rich selenium
- powder
- natto
- selenium
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 194
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 194
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 185
- 235000013557 nattō Nutrition 0.000 title claims abstract description 148
- 239000000843 powder Substances 0.000 claims abstract description 88
- 229940094952 green tea extract Drugs 0.000 claims abstract description 26
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 26
- 229940086319 nattokinase Drugs 0.000 claims abstract description 18
- 108010073682 nattokinase Proteins 0.000 claims abstract description 18
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 15
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 10
- 229950001002 cianidanol Drugs 0.000 claims abstract description 10
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 9
- 208000026106 cerebrovascular disease Diseases 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 108010074686 Selenoproteins Proteins 0.000 claims description 10
- 102000008114 Selenoproteins Human genes 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 9
- 235000005487 catechin Nutrition 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- -1 selenium polysaccharide Chemical class 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 6
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000010439 isomalt Nutrition 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 230000009849 deactivation Effects 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims description 2
- 235000020188 drinking water Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 229940083466 soybean lecithin Drugs 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 27
- 208000007536 Thrombosis Diseases 0.000 abstract description 26
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 235000012000 cholesterol Nutrition 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract description 4
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 108010022197 lipoprotein cholesterol Proteins 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 4
- 230000001906 cholesterol absorption Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 description 11
- 238000001514 detection method Methods 0.000 description 8
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 description 7
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 7
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 229960001913 mecysteine Drugs 0.000 description 7
- 229960002718 selenomethionine Drugs 0.000 description 7
- 239000007910 chewable tablet Substances 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000002537 thrombolytic effect Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003346 selenoethers Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000545744 Hirudinea Species 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- BUGBHKTXTAQXES-AHCXROLUSA-N Selenium-75 Chemical compound [75Se] BUGBHKTXTAQXES-AHCXROLUSA-N 0.000 description 1
- BNSWSSGKYAJNRB-RGMNGODLSA-N [Se].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Se].C(CC)N[C@@H](CCO)C(=O)O BNSWSSGKYAJNRB-RGMNGODLSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- BUGBHKTXTAQXES-DBXDQKISSA-N selenium-70 Chemical compound [70Se] BUGBHKTXTAQXES-DBXDQKISSA-N 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
体检项目 | 服用前(mmol/l) | 服用后(mmol/l) |
总胆固醇 | 6.3 | 4.3 |
高密度脂蛋白胆固醇 | 1.7 | 1.12 |
低密度脂蛋白胆固醇 | 2.03 | 3.4 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310158684.3A CN103230478B (zh) | 2013-05-02 | 2013-05-02 | 一种富硒纳豆制品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310158684.3A CN103230478B (zh) | 2013-05-02 | 2013-05-02 | 一种富硒纳豆制品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103230478A CN103230478A (zh) | 2013-08-07 |
CN103230478B true CN103230478B (zh) | 2014-12-03 |
Family
ID=48878593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310158684.3A Active CN103230478B (zh) | 2013-05-02 | 2013-05-02 | 一种富硒纳豆制品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103230478B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256407B (zh) * | 2014-10-09 | 2017-12-26 | 南京农业大学 | 一种功能性纳豆咀嚼片及其生产工艺 |
CN105054076B (zh) * | 2015-08-25 | 2017-09-19 | 广州金酮医疗科技有限公司 | 一种有助于改善阿尔兹海默症的营养组合物及其应用 |
CN105998726A (zh) * | 2016-05-20 | 2016-10-12 | 王思烨 | 一种纳豆蛋白粉 |
CN106889410B (zh) * | 2017-01-17 | 2021-01-08 | 陕西宏梁食品科技有限公司 | 一种高活菌纳豆固体饮料及其制备方法 |
CN106954797A (zh) * | 2017-03-11 | 2017-07-18 | 北京中科卓尔生物科技有限公司 | 多肽纳豆粉及其制备方法 |
CN106820127A (zh) * | 2017-03-11 | 2017-06-13 | 北京中科卓尔生物科技有限公司 | 富硒纳豆精粉及其制作方法 |
CN106942608A (zh) * | 2017-03-11 | 2017-07-14 | 北京中科卓尔生物科技有限公司 | 纳豆精粉及其制作方法 |
CN107094902A (zh) * | 2017-04-26 | 2017-08-29 | 合肥华创现代农业科技有限公司 | 豆制品及其制备方法 |
CN107125326A (zh) * | 2017-04-26 | 2017-09-05 | 合肥华创现代农业科技有限公司 | 豆类食品及其制备方法 |
CN110897164A (zh) * | 2019-12-26 | 2020-03-24 | 广州莱可福生物科技有限公司 | 一种含有植物甾醇的组合物及其改善血糖的用途 |
CN115650783A (zh) * | 2022-10-31 | 2023-01-31 | 迦硒(上海)科技有限公司 | 一种富硒植物营养液 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444273B (zh) * | 2007-11-22 | 2013-04-24 | 何煜 | 一种保健品口腔速释制剂及其制造方法 |
CN101791011A (zh) * | 2009-12-31 | 2010-08-04 | 苏州硒谷科技有限公司 | 一种富硒大豆粉的生产方法 |
CN102872306B (zh) * | 2012-09-25 | 2014-04-09 | 深圳市安美信生物医药科技有限公司 | 治疗心脑血管疾病的复方富硒中药组合物及其制备方法 |
-
2013
- 2013-05-02 CN CN201310158684.3A patent/CN103230478B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103230478A (zh) | 2013-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103230478B (zh) | 一种富硒纳豆制品 | |
CN104473249B (zh) | 一种松花粉的液体制剂及其制备方法 | |
TWI516280B (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
CN102224891A (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
CN107019211A (zh) | 制备具有补肾强肾功能的植物酵素的发酵组合物及制法 | |
CN104222407A (zh) | 野菊花茶保健饮料 | |
KR20240011214A (ko) | 대사질환의 치료 또는 예방용 조성물 | |
CN107252095A (zh) | 复合酵素及其制备方法 | |
CN107050073A (zh) | 一种增强记忆、减缓大脑衰老的保健品及其制备方法 | |
KR100994196B1 (ko) | 마늘 청국장 발효액의 제조방법 | |
CN106880040A (zh) | 制备具有适用于风湿骨关节病人调理养护的植物酵素的发酵组合物及制法 | |
CN105998726A (zh) | 一种纳豆蛋白粉 | |
JP2010100663A (ja) | タマネギ発酵物を含有する酵素阻害剤 | |
JP2005097222A (ja) | タマネギ発酵物 | |
CN103798667B (zh) | 菌茶红枣山楂糕及其制作方法 | |
CN109645295A (zh) | 一种维持心血管***健康的雨生红球藻虾青素固体饮料 | |
CN109820123A (zh) | 一种改善微循环的植物饮品及其制备方法 | |
KR101034986B1 (ko) | 혼합 생약추출물을 유효성분으로 함유하는 숙취해소용 조성물 | |
KR20180108515A (ko) | 수면장애 개선을 위한 조성물 및 그 제조방법 | |
CN108094990A (zh) | 一种提高脑力的能量果冻 | |
CN103584244A (zh) | 清热润肺饮料其制备方法 | |
CN103584226B (zh) | 清热降火的饮料及其制备方法 | |
TWI337541B (en) | A composition comprising lactobacillus sp. pm308 composition for treating obesity, ameliorating endomorph body type, decreasing body fat ratio and reducing cholesterol | |
KR20050086788A (ko) | 파파야 퓌레 및 그의 용도 | |
CN105077430A (zh) | 一种滋阴润肺的清肺饮品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU HONGTAI MEDICAL TECHNOLOGY CO., LTD. Effective date: 20141031 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510630 GUANGZHOU, GUANGDONG PROVINCE TO: 510530 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141031 Address after: 510530 Guangdong province high tech Industrial Development Zone, Science City, Kaiyuan Avenue, building, floor 11, C1, Fifth Applicant after: GUANGZHOU CINJEP BIOTECHNOLOGY Co.,Ltd. Applicant after: GUANGZHOU HTIDE MEDICAL TECHNOLOGY Co.,Ltd. Address before: 510630 first floor, No. 20 middle road, Tianhe hi tech Industrial Park, Guangdong, Guangzhou Applicant before: GUANGZHOU CINJEP BIOTECHNOLOGY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: GUANGZHOU HONGTAI MEDICAL TECHNOLOGY CO., LTD. Effective date: 20150805 Owner name: TONGTAI MYOCARDIAL AND CEREBRAL HEALTH MANAGEMENT Free format text: FORMER OWNER: GUANGZHOU CINJEP BIOTECHNOLOGY CO., LTD. Effective date: 20150805 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150805 Address after: 309, room 11, 510630 software Road, Guangdong, Guangzhou, Tianhe District Patentee after: TUNETAI HEART AND BRAIN HEALTH MANAGEMENT Co.,Ltd. Address before: 510530 Guangdong province high tech Industrial Development Zone, Science City, Kaiyuan Avenue, building, floor 11, C1, Fifth Patentee before: GUANGZHOU CINJEP BIOTECHNOLOGY Co.,Ltd. Patentee before: GUANGZHOU HTIDE MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190116 Address after: 510000 Room 303, 3/F, No. 11 Software Road, Tianhe Software Park, Tianhe District, Guangzhou City, Guangdong Province (This residence is for office use only) Patentee after: GUANGZHOU KETO MEDICAL TECHNOLOGY Co.,Ltd. Address before: Room 309, No. 11 Software Road, Tianhe District, Guangzhou City, Guangdong Province Patentee before: TUNETAI HEART AND BRAIN HEALTH MANAGEMENT Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191210 Address after: 510000, C1 building, No. 11, Kaiyuan Avenue, Science City, Guangzhou hi tech Industrial Development Zone, Guangdong, Fifth Patentee after: Guangzhou Jin Tong special medicals Food Co.,Ltd. Address before: 510000 Room 303, 3/F, No. 11 Software Road, Tianhe Software Park, Tianhe District, Guangzhou City, Guangdong Province (This residence is for office use only) Patentee before: GUANGZHOU KETO MEDICAL TECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Selenium-rich natto product Effective date of registration: 20200610 Granted publication date: 20141203 Pledgee: Senbao Branch of Guangzhou Bank Co.,Ltd. Pledgor: Guangzhou Jin Tong special medicals Food Co.,Ltd. Registration number: Y2020440000132 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210903 Granted publication date: 20141203 Pledgee: Senbao Branch of Guangzhou Bank Co.,Ltd. Pledgor: Guangzhou Jin Tong special medicals Food Co.,Ltd. Registration number: Y2020440000132 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Selenium enriched natto product Effective date of registration: 20210910 Granted publication date: 20141203 Pledgee: Tianhe sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: Guangzhou Jin Tong special medicals Food Co.,Ltd. Registration number: Y2021980009192 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221230 Granted publication date: 20141203 Pledgee: Tianhe sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: Guangzhou Jin Tong special medicals Food Co.,Ltd. Registration number: Y2021980009192 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |